PMID: 1364155Nov 1, 1992

Relevant pharmacologic data as a guide for use of beta-blockers in psychiatry

L'Encéphale
A Heim, J M Vanelle

Abstract

In addition to their competitive blockade of the beta-receptors, beta-adrenergic-blocking drugs possess ancillary properties that may modulate their clinical effects. Among these properties, beta 1-selectivity, intrinsic sympathomimetic activity, lipid solubility, may affect pharmacokinetic and pharmacodynamic properties of beta-blockers. It could appear that lipid soluble drugs gain access to the Central Nervous System (CNS) more easily. But CNS effects of beta-blockers are probably modulated by other parameters. With those pharmacological data, the authors propose briefly a schematic use of main beta-blockers in psychiatry.

Related Concepts

Adrenergic beta-Antagonists
Diagnosis, Psychiatric
Brain
Total Body Clearance Rate
Plasma Protein Binding Capacity

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.